1. University of Michigan (4 from 3,390 patents)

2. Temple University (3 from 412 patents)

3. Other (1 from 832,912 patents)

4. Thromgen, Inc. (1 from 1 patent)

1. 7879792 - Synthetic peptide inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4

2. 7074765 - Synthetic peptide analogs of Arg-Pro-Pro-Gly-Phe as selective inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4

3. 6982249 - Bradykinin analogs as selective inhibitors of cell activation

4. 6544750 - Peptide analogs as selective inhibitors of thrombin activation of protease activated receptor 1

5. 6143719 - Bradykinin analogs as selective thrombin inhibitors

6. 5472945 - Modulation of blood pressure and inhibition of platelet activation with

7. 5047323 - Method for detecting human kininogen using monoclonal antibodies thereto

8. 4908431 - Monoclonal antibodies to human kininogen and methods of preparing same